Revenue: The sum of all revenue fields included for a company's operating activities.
Foghorn Therapeutics Inc. (FHTX) had Revenue of $16.07M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$16.07M |
$-7.19M |
|
-- |
|
$16.07M |
|
$24.88M |
|
$-8.80M |
|
$1.61M |
|
$-7.19M |
|
$-7.19M |
|
$-7.19M |
|
$-7.19M |
|
$-7.19M |
|
$-7.19M |
|
$-8.80M |
|
$-9.19M |
|
70.63M |
|
70.63M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$170.05M |
|
$1.50M |
|
$33.35M |
|
$203.39M |
|
$50.58M |
|
-- |
|
$233.85M |
|
$284.43M |
|
$-81.04M |
|
$-81.04M |
|
$-81.04M |
|
58.71M |
|
| Cash Flow Statement Financials | |
$-43.11M |
|
$-20.69M |
|
$49.75M |
|
$84.13M |
|
$70.08M |
|
$-14.05M |
|
$4.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-54.78% |
|
-54.78% |
|
-- |
|
-44.74% |
|
-44.74% |
|
$-43.16M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
8.87% |
|
8.87% |
|
-3.54% |
|
8.87% |
|
$-1.38 |
|
$-0.61 |
|
$-0.61 |
|